OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SHPJ.J58

Shoprite Holdings Ltd

Food Retail & DistributionVerified

Shoprite Holdings Ltd has a fully diluted share count of 540.66 million, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability metrics are not available in the current dataset, and no industry-specific preferred metrics are provided for comparison. This limits the ability to assess Shoprite's performance relative to its peers in the Food Retail & Distribution industry. The company's revenue concentration and geographic exposure are not disclosed in the available data. Without segment or geographic breakdowns, it is not possible to evaluate the diversification of Shoprite's revenue streams or its exposure to regional economic conditions. Growth trajectory is not quantified in the current dataset, and no numeric deltas are provided for the current or next fiscal year. Analysts have issued a mean price target of 315.56 ZAR, with a median of 310.00 ZAR, suggesting moderate optimism about the stock's future performance. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The dilution risk is currently low, as there is no evidence of dilutive instruments or recent equity issuance. Recent events include analyst price targets and recommendations, with a mean recommendation of 1.80 (on a scale from 1 to 5), indicating a generally positive outlook. However, no recent filings or transcripts are available to provide additional context on the company's strategic direction or operational performance.

30-day price · SHPJ.J+1717.00 (+6.2%)
Low$27010.00High$29607.00Close$29297.00As of17 May, 00:00 UTC
Profile
CompanyShoprite Holdings Ltd
TickerSHPJ.J
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Shoprite Holdings Ltd operates as a food and drug retailer in the Consumer Non-Cyclicals sector, generating revenue primarily through the sale of groceries and household goods.

Classification. Shoprite is classified under the Food Retail & Distribution industry within the Food & Drug Retailing business sector, with a high confidence level of 0.92.

Shoprite Holdings Ltd has a fully diluted share count of 540.66 million, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability metrics are not available in the current dataset, and no industry-specific preferred metrics are provided for comparison. This limits the ability to assess Shoprite's performance relative to its peers in the Food Retail & Distribution industry. The company's revenue concentration and geographic exposure are not disclosed in the available data. Without segment or geographic breakdowns, it is not possible to evaluate the diversification of Shoprite's revenue streams or its exposure to regional economic conditions. Growth trajectory is not quantified in the current dataset, and no numeric deltas are provided for the current or next fiscal year. Analysts have issued a mean price target of 315.56 ZAR, with a median of 310.00 ZAR, suggesting moderate optimism about the stock's future performance. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The dilution risk is currently low, as there is no evidence of dilutive instruments or recent equity issuance. Recent events include analyst price targets and recommendations, with a mean recommendation of 1.80 (on a scale from 1 to 5), indicating a generally positive outlook. However, no recent filings or transcripts are available to provide additional context on the company's strategic direction or operational performance.
Key takeaways
  • Shoprite Holdings Ltd is a food and drug retailer with a high classification confidence in the Food Retail & Distribution industry.
  • The company has no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities.
  • Analysts have issued a mean price target of 315.56 ZAR, with a median of 310.00 ZAR, suggesting moderate optimism about the stock's future performance.
  • Liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
  • No segment or geographic breakdowns are available, limiting the ability to evaluate the diversification of Shoprite's revenue streams.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyZAR
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$168.03B$9.66B$4.84B$7.39B
FY-3$183.87B$11.05B$5.71B$6.78B
FY-2$214.96B$12.34B$5.89B$6.76B
FY-1$232.09B$12.66B$6.25B$6.17B
FY0$252.70B$14.94B$7.58B$8.44B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$77.07B$21.08B$7.95B
FY-3$91.46B$25.48B$10.66B
FY-2$102.45B$26.13B$12.55B
FY-1$112.33B$27.79B$11.73B
FY0$124.94B$30.19B$9.95B
PeriodOCFCapExFCFSBC
FY-4$7.98B-$3.22B$7.39B
FY-3$6.69B-$5.13B$6.78B
FY-2$9.83B-$6.69B$6.76B
FY-1$13.84B-$7.73B$6.17B
FY0$10.98B-$8.00B$8.44B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Food & Drug Retailing · cohort 184 companies
MetricSHPJ.JActivity
Op margin3.1% medp25 1.2% · p75 6.8%
Net margin2.0% medp25 0.7% · p75 4.1%
Gross margin26.1% medp25 17.2% · p75 32.0%
CapEx / revenue-2.5% medp25 -4.6% · p75 -1.4%
Debt / equity56.0% medp25 16.8% · p75 121.1%
Observations
IR observations
Mean price target315.56 ZAR
Median price target310.00 ZAR
High price target348.00 ZAR
Low price target298.00 ZAR
Mean recommendation1.80 (1=strong buy, 5=strong sell)
Strong-buy count4.00
Buy count4.00
Hold count2.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate14.77 ZAR
Last actual EPS14.27 ZAR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 11:28 UTC#3f6b6acc
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 10:22 UTCJob: fa0b08f2